VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹2.90 Cr | ₹10 Cr | ₹8.85 Cr | ₹7.95 Cr | ₹7.38 Cr |
What is the latest Long Term Provisions ratio of VENUS REMEDIES ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹2.90 Cr |
| Mar2024 | ₹10 Cr |
| Mar2023 | ₹8.85 Cr |
| Mar2022 | ₹7.95 Cr |
| Mar2021 | ₹7.38 Cr |
How is Long Term Provisions of VENUS REMEDIES Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹2.90 Cr | -71.74 | |
| Mar2024 | ₹10 Cr | 15.96 | |
| Mar2023 | ₹8.85 Cr | 11.21 | |
| Mar2022 | ₹7.95 Cr | 7.84 | |
| Mar2021 | ₹7.38 Cr | - | |
Compare Long Term Provisions of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹2,503.4 Cr | 5.8% | 45.6% | 358.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,924.0 Cr | -0.3% | 3.4% | 12.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,619.0 Cr | -2.5% | -1.2% | -1.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹156,450.0 Cr | 2.4% | 5.2% | 47.2% | Stock Analytics | |
| CIPLA | ₹118,361.0 Cr | 2.2% | 4.8% | -3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹113,253.0 Cr | 4.3% | 4.1% | 4.5% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | 5.8% |
45.6% |
358.2% |
| SENSEX | -0.8% |
0.8% |
-7.2% |
You may also like the below Video Courses